Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma
Simon Baldacci, V. Grégoire, Enrico Patrucco, Roberto Chiarle, Philippe Jamme, Eric Wasielewski, C. Descarpentries, Marie‐Christine Copin, Mark M. Awad, Alexis B. Cortot
Topics & Concepts
NivolumabMedicineCeritinibLung cancerOncologyAnaplastic lymphoma kinaseAdenocarcinomaImmunotherapyInternal medicineGene rearrangementComplete responseImmunohistochemistryChemotherapyCancerGeneBiochemistryMalignant pleural effusionChemistryLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics